Apotea AB
No trades
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
2.20 SEK
228.70 M SEK
7.20 B SEK
44.70 M
About Apotea AB
Sector
Industry
CEO
Pär Johan Svärdson
Website
Headquarters
Stockholm
Founded
2003
IPO date
Dec 6, 2024
Identifiers
2
ISIN SE0023313762
Apotea AB engages in the provision of an online pharmacy that sells a range of both non-prescription and prescription drugs. It offers medicine for allergy, face, animal, fever and pain, cold, parent and child, aids and accessories, skin and hair, health food, hands and feet, stomach and intestine, mouth and teeth, travel packaging, stop smoking, wound, training and weight, vitamins and minerals, and eye and ear. The company was founded by Marie-Louise Jansson, Pär Johan Svärdson, and Susanne Söderberg in 2003 and is headquartered in Stockholm, Sweden.
Related stocks
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Weight 0.01%
Market value 111.89 K
Weight 0.03%
Market value 92.44 K
Weight 0.01%
Market value 44.84 K
Weight 0.32%
Market value 17.05 K
Explore more ETFs
Frequently asked questions
The current price of APOTEA is 56.86 SEK — it has decreased by −0.46% in the past 24 hours. Watch Apotea AB stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OMXSTO exchange Apotea AB stocks are traded under the ticker APOTEA.
APOTEA stock has fallen by −3.63% compared to the previous week, the month change is a −3.71% fall, over the last year Apotea AB has showed a −24.55% decrease.
We've gathered analysts' opinions on Apotea AB future price: according to them, APOTEA price has a max estimate of 95.00 SEK and a min estimate of 68.00 SEK. Watch APOTEA chart and read a more detailed Apotea AB stock forecast: see what analysts think of Apotea AB and suggest that you do with its stocks.
APOTEA reached its all-time high on Jul 28, 2025 with the price of 122.00 SEK, and its all-time low was 56.01 SEK and was reached on Mar 13, 2026. View more price dynamics on APOTEA chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
APOTEA stock is 1.98% volatile and has beta coefficient of 0.68. Track Apotea AB stock price on the chart and check out the list of the most volatile stocks — is Apotea AB there?
Yes, you can track Apotea AB financials in yearly and quarterly reports right on TradingView.
Apotea AB is going to release the next earnings report on Apr 29, 2026. Keep track of upcoming events with our Earnings Calendar.
APOTEA earnings for the last quarter are 0.12 SEK per share, whereas the estimation was 0.53 SEK resulting in a −77.36% surprise. The estimated earnings for the next quarter are 0.58 SEK per share. See more details about Apotea AB earnings.
Apotea AB revenue for the last quarter amounts to 1.85 B SEK, despite the estimated figure of 1.91 B SEK. In the next quarter, revenue is expected to reach 1.92 B SEK.
APOTEA net income for the last quarter is 15.40 M SEK, while the quarter before that showed 69.60 M SEK of net income which accounts for 0.00% change. Track more Apotea AB financial stats to get the full picture.
Apotea AB dividend yield was 0.65% in 2025, and payout ratio reached 27.30%. The year before the numbers were 0.00% and 0.00% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Apotea AB EBITDA is 450.60 M SEK, and current EBITDA margin is 6.26%. See more stats in Apotea AB financial statements.
Like other stocks, APOTEA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Apotea AB stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Apotea AB technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Apotea AB stock shows the sell signal. See more of Apotea AB technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.